| 摘要 |
FIELD: medicine.SUBSTANCE: group of invention presents methods for prevention and treatment of osteolysis, cancer metastases and bone loss caused by cancer metastases by the introduction of M-CSF antagonist combined with bisphosphonate in an individual.EFFECT: said group of inventions enables achieving effective treatment of the osteolytic disorder.21 cl, 32 dwg, 3 tbl, 4 ex |
